The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNb Distres Red Regulatory News (NBDG)

Share Price Information for Nb Distres Red (NBDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 28.00
Ask: 34.00
Change: 0.00 (0.00%)
Spread: 6.00 (21.429%)
Open: 31.00
High: 31.00
Low: 31.00
Prev. Close: 31.00
NBDG Live PriceLast checked at -
NB Distressed Debt New Global shares is an Investment Trust

To provide investors with attractive risk-adjusted returns through opportunistic exposure to stressed and special situation credit-related investments, while seeking to limit downside risk.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update: 4Q19 - NBDD, NBDX, NBDG Classes

4 Feb 2020 07:00

RNS Number : 8312B
NB Distressed Debt Invest. Fd. Ltd
04 February 2020
 

4 February 2020

 

NB Distressed Debt Investment Fund Limited

 

4th Quarter 2019 Portfolio Update - All Share Classes

 

 

The Company's factsheets for the quarter ending 31 December 2019 are available via the following links:

 

NBDD - Ordinary Share Class

http://www.rns-pdf.londonstockexchange.com/rns/8312B_1-2020-2-4.pdf

 

NBDX - Extended Life Share Class

http://www.rns-pdf.londonstockexchange.com/rns/8312B_2-2020-2-4.pdf

 

NBDG - Global Share Class

http://www.rns-pdf.londonstockexchange.com/rns/8312B_3-2020-2-4.pdf

 

or via the Company's website www.nbddif.com 

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

- ENDS -

 

 

For further information please contact:

 

KL Communications Tel: +44 (0)20 3995 6673

Charles Gorman nbdd@kl-communications.com

 

-----

 

This document has been issued by NB Distressed Debt Investment Fund Limited (the "Company"), and should not be taken as an offer, invitation or inducement to engage in any investment activity and is solely for the purpose of providing information about the Company. This document does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any share in the Company or securities in any other entity, in any jurisdiction.

 

The Company is a closed-ended investment company incorporated and registered in Guernsey and is governed under the provisions of the Companies (Guernsey) Law, 2008 (as amended), and the Registered Collective Investment Scheme Rules 2008 issued by the Guernsey Financial Services Commission ("GFSC"). It is a non-cellular company limited by shares and has been declared by the GFSC to be a registered closed-ended collective investment scheme. The Company's shares are admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market for listed securities.

 

Neuberger Berman Europe Limited ("NBEL"), the Company's Manager, is authorised and regulated by the Financial Conduct Authority ("FCA") and is registered in England and Wales, at Lansdowne House, 57 Berkeley Square, London, W1J 6ER and is also a Registered Investment Adviser with the Securities and Exchange Commission ("SEC") in the U.S. and regulated by the Dubai Financial Services Authority.

 

This document is presented solely for information purposes and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. We do not represent that this information, including any third party information, is accurate or complete and it should not be relied upon as such. Any views or opinions expressed may not reflect those of the Company or NBEL as a whole. All information is current as of the date of this material and is subject to change without notice. No part of this document may be reproduced in any manner without prior written permission of the Company and NBEL.

 

There is no guarantee that any of the goals, targets or objectives described in this factsheet will be achieved. This factsheet may contain "forward-looking information" which can be identified by the use of forward looking terminology such as "may", "will", "should", "expect", "anticipate", "target", "project", "estimate", "intend", "continue" or "believe" or the negatives thereof or other variations thereon or comparable terminology. Such statements are not purely historical in nature, and may include, among other things, projections, forecasts or estimates of cash flows, yields or returns, scenario analyses and proposed or expected portfolio composition. The forward-looking information contained herein is based upon certain assumptions about future events or conditions and is intended only to illustrate hypothetical results under those assumptions (not all of which will be specified herein). Not all relevant events or conditions may have been considered in developing such assumptions. The success or achievement of various results and objectives is dependent on a multitude of factors, many of which are beyond the control of the Company and Neuberger Berman. Actual volatility and returns will depend on a variety of factors including overall market conditions and the ability of the Company and Neuberger Berman to implement its process, investment strategy and risk management policies. No representations are made as to the accuracy of such estimates or projections or that such projections will be realised. Actual events or conditions are unlikely to be consistent with, and may differ materially from, those assumed.

 

An investment in the Company involves risks, with the potential for above average risk, and is only suitable for people who are in a position to take such risks. No recommendation or advice is being given as to whether any investment or strategy is suitable for a particular investor. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of any investment, and should consult its own legal counsel and financial, actuarial, accounting, regulatory and tax advisers to evaluate any such investment. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. Investment in the Company should not constitute a substantial proportion of an investor's portfolio and may not be appropriate for all investors. Diversification and asset class allocation do not guarantee profit or protect against loss.

 

Past performance is not a reliable indicator of current or future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The performance data does not take account of the commissions and costs incurred on the issue and redemption of units.

 

The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

 

Tax treatment depends on the individual circumstances of each investor and may be subject to change, investors are therefore recommended to seek independent tax advice.

 

This document, and the information contained therein, is not for viewing, release, distribution or publication in or into the United States, Canada, Japan, South Africa or any other jurisdiction where applicable laws prohibit its release, distribution or publication, and will not be made available to any national, resident or citizen of the United States, Canada, Japan or South Africa. The distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States and the laws of other jurisdictions.

 

The Company's shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The shares may not be offered, sold, resold, pledged, delivered, distributed or otherwise transferred, directly or indirectly, into or within the United States, or to, or for the account or benefit of, US persons (as defined in Regulation S under the Securities Act). No public offering of the shares is being made in the United States.

 

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act") and, as such, holders of the shares will not be entitled to the benefits of the Investment Company Act. No offer, sale, resale, pledge, delivery, distribution or transfer of the shares may be made except under circumstances that will not result in the Company being required to register as an investment company under the Investment Company Act. In addition, the shares are subject to restrictions on transferability and resale in certain jurisdictions and may not be transferred or resold except as permitted under applicable securities laws and regulations. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdictions.

 

The "Neuberger Berman" name and logo are registered service marks of Neuberger Berman Group LLC.

 

© 2020 Neuberger Berman Group LLC. All rights reserved.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUZZGGZGDZGGZG
Date   Source Headline
26th Apr 20247:00 amRNSAnnual Financial Report
25th Apr 20246:00 pmRNSNet Asset Value(s)
24th Apr 20246:00 pmRNSNet Asset Value(s)
23rd Apr 20246:00 pmRNSNet Asset Value(s)
22nd Apr 20246:00 pmRNSNet Asset Value(s)
19th Apr 20246:00 pmRNSNet Asset Value(s)
18th Apr 20246:00 pmRNSNet Asset Value(s)
17th Apr 20246:00 pmRNSNet Asset Value(s)
16th Apr 20246:00 pmRNSNet Asset Value(s)
15th Apr 20246:00 pmRNSNet Asset Value(s)
12th Apr 20246:00 pmRNSNet Asset Value(s)
11th Apr 20246:00 pmRNSNet Asset Value(s)
10th Apr 20246:00 pmRNSNet Asset Value(s)
9th Apr 20246:00 pmRNSNet Asset Value(s)
8th Apr 20246:00 pmRNSNet Asset Value(s)
4th Apr 20246:00 pmRNSNet Asset Value(s)
3rd Apr 20246:00 pmRNSNet Asset Value(s)
2nd Apr 20246:00 pmRNSNet Asset Value(s)
28th Mar 20246:00 pmRNSNet Asset Value(s)
28th Mar 20245:30 pmRNSTotal Voting Rights
27th Mar 20246:00 pmRNSNet Asset Value(s)
26th Mar 20246:00 pmRNSNet Asset Value(s)
25th Mar 20246:00 pmRNSNet Asset Value(s)
22nd Mar 20246:00 pmRNSNet Asset Value(s)
21st Mar 20246:00 pmRNSNet Asset Value(s)
20th Mar 20246:00 pmRNSNet Asset Value(s)
19th Mar 20246:00 pmRNSNet Asset Value(s)
18th Mar 20246:00 pmRNSNet Asset Value(s)
15th Mar 20246:00 pmRNSNet Asset Value(s)
14th Mar 20246:00 pmRNSNet Asset Value(s)
13th Mar 20246:00 pmRNSNet Asset Value(s)
12th Mar 20246:00 pmRNSNet Asset Value(s)
11th Mar 20246:00 pmRNSNet Asset Value(s)
8th Mar 20246:00 pmRNSNet Asset Value(s)
7th Mar 20246:00 pmRNSNet Asset Value(s)
6th Mar 20246:00 pmRNSNet Asset Value(s)
5th Mar 20246:00 pmRNSNet Asset Value(s)
4th Mar 20246:00 pmRNSNet Asset Value(s)
1st Mar 20246:00 pmRNSNet Asset Value(s)
29th Feb 20246:00 pmRNSNet Asset Value(s)
29th Feb 20245:30 pmRNSTotal Voting Rights
28th Feb 20246:00 pmRNSNet Asset Value(s)
27th Feb 20246:00 pmRNSNet Asset Value(s)
26th Feb 20246:00 pmRNSNet Asset Value(s)
23rd Feb 20246:00 pmRNSNet Asset Value(s)
22nd Feb 20246:00 pmRNSNet Asset Value(s)
21st Feb 20246:00 pmRNSNet Asset Value(s)
20th Feb 20246:00 pmRNSNet Asset Value(s)
19th Feb 20246:00 pmRNSNet Asset Value(s)
16th Feb 20246:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.